Figure 3. Hepatic sections stained with hematoxylin and eosin in the control group (a), control group treated with CAY10500 (b), hepatocellular carcinoma (a), and hepatocellular carcinoma treated with CAY10500 (d), as well as mitotic score (e).

Yellow arrows represented hepatocytes showing vacuolar to ballooning degeneration. Black arrows represented mild regression of hepatic fibrosis. * Significant difference as compared with the control group at p<0.05. # Significant difference as compared with the HCC group at p<0.05. The scale bar represented 50 µm.

HCC, hepatocellular carcinoma